Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2020-04-20 Audit Report / Informat…
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
Auditor report (consolidated accounts) (ENG).pdf
Audit Report / Information Classification · 99% confidence The document explicitly contains the title "Statutory auditor's report to the shareholders' meeting for the year ended 31 december 2019 - Consolidated financial statements". It details the scope of the audit, provides an "Unqualified opinion" on the consolidated financial statements prepared under IFRS, discusses Key Audit Matters (like Revenue recognition), and outlines the responsibilities of both the board of directors and the statutory auditor. This content is the definition of a formal Audit Report, specifically related to the annual financial statements, but it is not the full Annual Report (10-K) itself, as it is focused solely on the auditor's findings and opinion. Therefore, the most appropriate classification is Audit Report / Information (AR). FY 2019
2020-04-20 English
AGM EGM 2020 - Revised vote by mail (DUT) (final).pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is explicitly titled "FORMULIER VOOR STEMMING PER BRIEF" (Form for Voting by Mail) for the "GEWONE EN BUITENGEWONE ALGEMENE AANDEELHOUDERSVERGADERINGEN" (Ordinary and Extraordinary General Shareholders' Meetings) scheduled for May 8, 2020. This form provides instructions and spaces for shareholders to cast their votes on various agenda items, including the approval of annual accounts (for the year ended December 31, 2019), remuneration reports, and the appointment/reappointment of directors and the auditor. This material is directly related to soliciting shareholder votes and providing necessary information for the General Meeting. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to request votes for meetings. While it relates to the AGM, the specific function is soliciting votes via proxy/mail, making PSI more precise than AGM-R (which is for presentations/materials shared *during* the meeting).
2020-04-20 Dutch
AGM EGM 2020 - Revised proxy (ENG) (final).pdf
Proxy Solicitation & Information Statement Classification · 99% confidence The document is explicitly titled "PROXY" for "ANNUAL AND EXTRAORDINARY SHAREHOLDERS' MEETINGS" scheduled for May 8, 2020. It contains detailed instructions on how a shareholder can appoint a proxy holder to vote on various agenda items, including the approval of financial statements, discharge of directors, and re-appointment/appointment of directors. This document is a solicitation form used to gather shareholder votes ahead of a general meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). Although it discusses items typically found in an Annual Report (like financial statements and remuneration reports), the document itself is the mechanism for voting on those items, not the report itself.
2020-04-20 English
Commissarisverslag (enkelvoudige jaarrekening) (NL).pdf
Audit Report / Information Classification · 98% confidence The document is titled 'Verslag van de commissaris aan de algemene vergadering over het boekjaar afgesloten op 31 december 2019 - Jaarrekening' (Commissioner's Report to the General Meeting on the financial year ended December 31, 2019 - Annual Accounts). It contains an 'Oordeel zonder voorbehoud' (Unqualified Opinion) regarding the 'jaarrekening' (annual accounts) and details the responsibilities of the commissioner (auditor) according to Belgian accounting standards and ISAs. This structure is characteristic of a formal Audit Report or the auditor's section within a larger annual filing. Since it is explicitly a 'Verslag van de commissaris' (Commissioner's Report) focusing on the audit results of the annual accounts, it aligns best with the 'Audit Report / Information' category (AR), rather than the full '10-K' which is the comprehensive annual report itself, especially given the focus on the auditor's opinion and verification duties. FY 2019
2020-04-20 Dutch
AGM EGM 2020 - 2019 annual report (ENG).pdf
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2019' and contains comprehensive sections including a message from the Chairman and CEO, business activities, corporate governance, consolidated annual accounts, statutory annual accounts, and an auditor's report. It covers the full fiscal year 2019 and provides detailed financial statements and management analysis, fitting the definition of an Annual Report (10-K). FY 2019
2020-04-20 English
AGM EGM 2020 - Board Report 7199 BCCA (DUT) (final).pdf
Capital/Financing Update Classification · 98% confidence The document is explicitly titled "BIJZONDER VERSLAG VAN DE RAAD VAN BESTUUR OVEREENKOMSTIG ARTIKEL 7:199 VAN HET WETBOEK VAN VENNOOTSCHAPPEN EN VERENIGINGEN" (Special Report of the Board of Directors pursuant to Article 7:199 of the Companies and Associations Code). This report details a proposal to renew the authorization for the Board of Directors to increase the company's capital within the limits of the authorized capital, which is a matter concerning capital structure and financing authority. This directly aligns with the definition of 'Capital/Financing Update' (CAP), as it seeks shareholder approval for a mechanism to raise capital flexibly. Although it relates to a future general meeting, the core content is the proposal for capital authorization, making CAP more specific than a general RPA or LTR.
2020-04-20 Dutch

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.